IBDEI0KY ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10269,1,4,0)
 ;;=4^042.
 ;;^UTILITY(U,$J,358.3,10269,1,5,0)
 ;;=5^HIV Disease (symptomatic)
 ;;^UTILITY(U,$J,358.3,10269,2)
 ;;=HIV Disease (symptomatic)^266500
 ;;^UTILITY(U,$J,358.3,10270,0)
 ;;=464.00^^67^673^2
 ;;^UTILITY(U,$J,358.3,10270,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10270,1,4,0)
 ;;=4^464.00
 ;;^UTILITY(U,$J,358.3,10270,1,5,0)
 ;;=5^Acute Laryngitis
 ;;^UTILITY(U,$J,358.3,10270,2)
 ;;=Acute Laryngitis^323469
 ;;^UTILITY(U,$J,358.3,10271,0)
 ;;=790.6^^67^673^1
 ;;^UTILITY(U,$J,358.3,10271,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10271,1,4,0)
 ;;=4^790.6
 ;;^UTILITY(U,$J,358.3,10271,1,5,0)
 ;;=5^Abnormal LFT's
 ;;^UTILITY(U,$J,358.3,10271,2)
 ;;=^87228
 ;;^UTILITY(U,$J,358.3,10272,0)
 ;;=780.60^^67^673^20
 ;;^UTILITY(U,$J,358.3,10272,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10272,1,4,0)
 ;;=4^780.60
 ;;^UTILITY(U,$J,358.3,10272,1,5,0)
 ;;=5^Fever
 ;;^UTILITY(U,$J,358.3,10272,2)
 ;;=^336764
 ;;^UTILITY(U,$J,358.3,10273,0)
 ;;=795.51^^67^673^55
 ;;^UTILITY(U,$J,358.3,10273,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10273,1,4,0)
 ;;=4^795.51
 ;;^UTILITY(U,$J,358.3,10273,1,5,0)
 ;;=5^Pos PPD w/o Active TB
 ;;^UTILITY(U,$J,358.3,10273,2)
 ;;=^340572
 ;;^UTILITY(U,$J,358.3,10274,0)
 ;;=482.9^^67^673^53
 ;;^UTILITY(U,$J,358.3,10274,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10274,1,4,0)
 ;;=4^482.9
 ;;^UTILITY(U,$J,358.3,10274,1,5,0)
 ;;=5^Pneumonia,Bacterial
 ;;^UTILITY(U,$J,358.3,10274,2)
 ;;=^12347
 ;;^UTILITY(U,$J,358.3,10275,0)
 ;;=571.42^^67^673^31
 ;;^UTILITY(U,$J,358.3,10275,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10275,1,4,0)
 ;;=4^571.42
 ;;^UTILITY(U,$J,358.3,10275,1,5,0)
 ;;=5^Hepatitis, Autoimunne
 ;;^UTILITY(U,$J,358.3,10275,2)
 ;;=^336610
 ;;^UTILITY(U,$J,358.3,10276,0)
 ;;=795.52^^67^673^54
 ;;^UTILITY(U,$J,358.3,10276,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10276,1,4,0)
 ;;=4^795.52
 ;;^UTILITY(U,$J,358.3,10276,1,5,0)
 ;;=5^Pos GMA Interferon w/o Active TB
 ;;^UTILITY(U,$J,358.3,10276,2)
 ;;=^340573
 ;;^UTILITY(U,$J,358.3,10277,0)
 ;;=682.0^^67^674^6
 ;;^UTILITY(U,$J,358.3,10277,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10277,1,4,0)
 ;;=4^682.0
 ;;^UTILITY(U,$J,358.3,10277,1,5,0)
 ;;=5^Cellulitis Of Face
 ;;^UTILITY(U,$J,358.3,10277,2)
 ;;=^271888
 ;;^UTILITY(U,$J,358.3,10278,0)
 ;;=681.00^^67^674^7
 ;;^UTILITY(U,$J,358.3,10278,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10278,1,4,0)
 ;;=4^681.00
 ;;^UTILITY(U,$J,358.3,10278,1,5,0)
 ;;=5^Cellulitis Of Finger NOS
 ;;^UTILITY(U,$J,358.3,10278,2)
 ;;=^271883
 ;;^UTILITY(U,$J,358.3,10279,0)
 ;;=682.7^^67^674^8
 ;;^UTILITY(U,$J,358.3,10279,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10279,1,4,0)
 ;;=4^682.7
 ;;^UTILITY(U,$J,358.3,10279,1,5,0)
 ;;=5^Cellulitis Of Foot
 ;;^UTILITY(U,$J,358.3,10279,2)
 ;;=^271895
 ;;^UTILITY(U,$J,358.3,10280,0)
 ;;=682.4^^67^674^9
 ;;^UTILITY(U,$J,358.3,10280,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10280,1,4,0)
 ;;=4^682.4
 ;;^UTILITY(U,$J,358.3,10280,1,5,0)
 ;;=5^Cellulitis Of Hand
 ;;^UTILITY(U,$J,358.3,10280,2)
 ;;=^271892
 ;;^UTILITY(U,$J,358.3,10281,0)
 ;;=682.6^^67^674^10
 ;;^UTILITY(U,$J,358.3,10281,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10281,1,4,0)
 ;;=4^682.6
 ;;^UTILITY(U,$J,358.3,10281,1,5,0)
 ;;=5^Cellulitis Of Leg
 ;;^UTILITY(U,$J,358.3,10281,2)
 ;;=^271894
 ;;^UTILITY(U,$J,358.3,10282,0)
 ;;=682.1^^67^674^11
 ;;^UTILITY(U,$J,358.3,10282,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10282,1,4,0)
 ;;=4^682.1
 ;;^UTILITY(U,$J,358.3,10282,1,5,0)
 ;;=5^Cellulitis Of Neck
 ;;^UTILITY(U,$J,358.3,10282,2)
 ;;=^271889
 ;;^UTILITY(U,$J,358.3,10283,0)
 ;;=376.01^^67^674^12
